Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Bisgaard Borup

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|March 25, 2022
Cavitating pulmonary lung lesions with more than one microbiological aetiologyMaria Bisgaard Borup, Casper Falster, Niels Jacobsen, et al.
Ugeskrift for Laeger|July 2, 2024
Martine Siw Nielsen, Maria Bisgaard Borup, Jens Kjeldsen, et al.
Medical Microbiology and Immunology|September 24, 2025
Diagnostic performance of circulating microRNA signatures for differentiating tuberculosis disease from tuberculosis infectionAnne Ahrens Østergaard, Stephanie Bjerrum, Kristian Assing, et al.
The European Respiratory Journal|November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthmaKjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Pulmonology|July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapyKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
BMJ Open Respiratory Research|March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysisKjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|March 25, 2022
Cavitating pulmonary lung lesions with more than one microbiological aetiologyMaria Bisgaard Borup, Casper Falster, Niels Jacobsen, et al.
Ugeskrift for Laeger|July 2, 2024
Martine Siw Nielsen, Maria Bisgaard Borup, Jens Kjeldsen, et al.
Medical Microbiology and Immunology|September 24, 2025
Diagnostic performance of circulating microRNA signatures for differentiating tuberculosis disease from tuberculosis infectionAnne Ahrens Østergaard, Stephanie Bjerrum, Kristian Assing, et al.
The European Respiratory Journal|November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthmaKjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Pulmonology|July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapyKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
BMJ Open Respiratory Research|March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysisKjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pageof 1